Cited by 77Pituitary Gland Disorders and TreatmentsGrowth Hormone and Insulin-like Growth FactorsGlioma Diagnosis and Treatment

Pituitary dysfunction following cranial radiotherapy for adult-onset nonpituitary brain tumours

Kyriakakis, Nikolaos, Lynch, Julie, Orme, Steve M., Gerrard, Georgina, Hatfield, Paul, Loughrey, Carmel, Short, Susan C., Murray, Robert D.·2016·Clinical Endocrinology

Abstract

OBJECTIVE: There are limited data concerning the evolution of radiation-induced hypopituitarism in adult-onset brain tumour (AO-BT) survivors, in part the consequence of the limited survival of many of these individuals. We aim to characterize the pituitary-related outcomes following cranial radiotherapy (cXRT) for adult-onset primary nonpituitary brain tumours. DESIGN: We retrospectively analysed longitudinal data of patients with AO-BT who received cXRT within a tertiary cancer referral centre. PATIENTS: A total of 107 adults (age 40·0 ± 13·1 years) followed for a median duration of 8 years following cXRT. MEASUREMENTS: Prevalence of radiotherapy-induced hypopituitarism. RESULTS: 94·4% received fractionated photon radiotherapy (median dose 54 Gy), while the remaining patients received proton beam or stereotactic radiotherapy. 88·8% of patients developed hypopituitarism during follow-up. The frequency of GH, gonadotrophin, ACTH and TSH deficiencies was 86·9% (severe GHD 64·5%, partial GHD 22·4%), 34·6%, 23·4% and 11·2%, respectively. ACTH deficiency was clinically significant, necessitating glucocorticoid replacement, in only 10·3% of cases. Hyperprolactinaemia developed in 15% of patients, which was persistent in only 50% of cases. Multiple pituitary hormone deficiencies were present in 47·7% of patients, encountered more frequently in patients with tumours in proximity to the sella. Longitudinal data analysis revealed accumulation of hormone deficits throughout the follow-up period, with incidence of all pituitary hormone deficiencies almost doubling between years 2 and 7 of follow-up. CONCLUSIONS: Pituitary dysfunction in AO-BT survivors following cXRT is a common, evolving, time-dependent phenomenon. It is important that deficits are identified early and replacement therapies introduced to optimize quality of life in these individuals, where prognosis is often guarded.

Integrity signals

Registry

Crossref · 10.1111/cen.12969

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kyriakakis, N., Lynch, J., Orme, S. M., Gerrard, G., Hatfield, P., Loughrey, C., Short, S. C., & Murray, R. D.
Affiliations
Leeds Teaching Hospitals NHS Trust (GB)
Corresponding author
Murray, Robert D.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2015-11-24
Volume
84
Issue
3
Pages
372-379
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W1848109215
Cited by
77
References
24
Citations by year
2026: 1 · 2025: 6 · 2024: 7 · 2023: 7 · 2022: 6 · 2021: 7 · 2020: 11 · 2019: 11 · 2018: 8 · 2017: 10 · 2016: 3
FWCI
6.08
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute for Health and Care Research (ACF-2016-02-005)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
Keywords
radiation-induced hypopituitarism, cranial irradiation, growth hormone deficiency, ACTH deficiency, gonadotropin deficiency, TSH deficiency, hyperprolactinemia, multiple pituitary hormone deficiency, hormone replacement therapy, proton beam radiotherapy, stereotactic radiotherapy
MeSH terms
Adrenocorticotropic Hormone, Adult, Brain Neoplasms, Dwarfism, Pituitary, Female, Follow-Up Studies, Humans, Hypopituitarism, Longitudinal Studies, Male, Middle Aged, Pituitary Gland, Retrospective Studies, Cranial Irradiation, Outcome Assessment, Health Care, Tertiary Care Centers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review